210 related articles for article (PubMed ID: 14747966)
1. [Linezolid in two premature babies with necrotizing enterocolitis and infection with vancomycin-resistant enterococcus].
Klingkowski U; Huth RG; Habermehl P; Knuf M
Klin Padiatr; 2004; 216(1):21-3. PubMed ID: 14747966
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid.
Ang JY; Lua JL; Turner DR; Asmar BI
Pediatr Infect Dis J; 2003 Dec; 22(12):1101-3. PubMed ID: 14688576
[TBL] [Abstract][Full Text] [Related]
3. [Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium].
Berberian G; Castro G; Fistolera S; Travaglianti M; Lopardo H; Mastroianni A; Rosanova MT
Rev Argent Microbiol; 2009; 41(1):34-8. PubMed ID: 19391524
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).
McNeil SA; Clark NM; Chandrasekar PH; Kauffman CA
Clin Infect Dis; 2000 Feb; 30(2):403-4. PubMed ID: 10671355
[No Abstract] [Full Text] [Related]
5. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
Kaplan SL; Deville JG; Yogev R; Morfin MR; Wu E; Adler S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB;
Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
[TBL] [Abstract][Full Text] [Related]
6. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
[TBL] [Abstract][Full Text] [Related]
8. Preliminary experience with the use of oral linezolid in infants for the completion of antibiotic therapy in the outpatient setting after admission to the pediatric intensive care unit.
Sullivan J; Tobias JD
Am J Ther; 2006; 13(6):473-7. PubMed ID: 17122526
[TBL] [Abstract][Full Text] [Related]
9. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
[TBL] [Abstract][Full Text] [Related]
10. Linezolid resistant enterococcus faecium.
McNicholas S; Hanahoe B; Higgins F; McAnena O; Corbett-Feeney G; Cormican M
Ir Med J; 2008; 101(7):225-6. PubMed ID: 18810787
[No Abstract] [Full Text] [Related]
11. Linezolid treatment of glycopeptide-resistant Enterococcus faecium in very low birth weight premature neonates.
Hoehn R; Groll AH; Schaefer V; Bauer K; Schloesser RL
Int J Antimicrob Agents; 2006 Mar; 27(3):256-8. PubMed ID: 16480855
[TBL] [Abstract][Full Text] [Related]
12. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
[TBL] [Abstract][Full Text] [Related]
13. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
Till M; Wixson RL; Pertel PE
Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
[TBL] [Abstract][Full Text] [Related]
14. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
Le J; Bookstaver PB; Rudisill CN; Hashem MG; Iqbal R; James CL; Sakoulas G
Ann Pharmacother; 2010 Dec; 44(12):2001-6. PubMed ID: 21119097
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
Noskin GA; Siddiqui F; Stosor V; Kruzynski J; Peterson LR
Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
[No Abstract] [Full Text] [Related]
16. [Our experience with linesolid usage in newborn children].
Atanasova V; Slavkova N; Rosmanova R
Akush Ginekol (Sofiia); 2007; 46 Suppl 1():60-2. PubMed ID: 18173016
[TBL] [Abstract][Full Text] [Related]
17. Linezolid for the treatment of complicated skin and skin structure infections in children.
Yogev R; Patterson LE; Kaplan SL; Adler S; Morfin MR; Martin A; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S172-7. PubMed ID: 14520143
[TBL] [Abstract][Full Text] [Related]
18. Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis.
Tsai TN; Wu CP; Peng MY; Giian CF; Lee SY; Lu JJ
Int J Clin Pract; 2006 Jun; 60(6):740-1. PubMed ID: 16805761
[TBL] [Abstract][Full Text] [Related]
19. EUCAST Technical Note on linezolid.
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
Clin Microbiol Infect; 2006 Dec; 12(12):1243-5. PubMed ID: 17121637
[No Abstract] [Full Text] [Related]
20. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium.
Pai MP; Rodvold KA; Schreckenberger PC; Gonzales RD; Petrolatti JM; Quinn JP
Clin Infect Dis; 2002 Nov; 35(10):1269-72. PubMed ID: 12410489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]